Cargando…
MiR-630 suppresses breast cancer progression by targeting metadherin
MicroRNAs have been integrated into tumorigenic programs as either oncogenes or tumor suppressor genes. The miR-630 was reported to be deregulated and involved in tumor progression of several human malignancies. However, its expression regulation shows diversity in different kinds of cancers and its...
Autores principales: | Zhou, Ci-Xiang, Wang, Chen-Long, Yu, An-Lu, Wang, Qiu-Yu, Zhan, Meng-Na, Tang, Jun, Gong, Xiu-Feng, Yin, Qian-Qian, He, Ming, He, Jian-Rong, Chen, Guo-Qiang, Zhao, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4811460/ https://www.ncbi.nlm.nih.gov/pubmed/26595523 |
Ejemplares similares
-
MiR-128 suppresses metastatic capacity by targeting metadherin in breast cancer cells
por: Cao, Danxia, et al.
Publicado: (2020) -
MiR-133b targets Sox9 to control pathogenesis and metastasis of breast cancer
por: Wang, Qiu-Yu, et al.
Publicado: (2018) -
MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma
por: Chen, Wei-xun, et al.
Publicado: (2016) -
miR-384 targets metadherin gene to suppress growth, migration, and invasion of gastric cancer cells
por: Wang, Fang
Publicado: (2019) -
MiR-124 targets Slug to regulate epithelial–mesenchymal transition and metastasis of breast cancer
por: Liang, Yong-Jun, et al.
Publicado: (2013)